Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins.
D000818:Animals; D001053:Apolipoproteins / Q000378:metabolism; D001120:Arginine; D003512:Cyclohexanones; D004285:Dogs; D005347:Fibroblasts / Q000378:metabolism*; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism*; D013045:Species Specificity
D001053:Apolipoproteins; D003512:Cyclohexanones; D008077:Lipoproteins, LDL; D011955:Receptors, Drug; D001120:Arginine